New Generic Approval: Methimazole Coated Tablets (ANADA 200-814)

2025-07-22T10:21:03-05:00July 22nd, 2025|Categories: News Release, Medication Safety, Veterinary Medicine, Veterinary Pharmacy, Veterinary Pharmacy - Small Animals|Tags: , |

New Generic Approval: Methimazole Coated Tablets (ANADA 200-814) Important Update for ACVP Members and Veterinary Pharmacy Professionals The FDA has approved Methimazole Coated Tablets under ANADA 200-814, a generic equivalent to the pioneer product Felimazole® (NADA 141-292), for the treatment of hyperthyroidism in cats. This approval offers veterinary pharmacy professionals a reliable, cost-effective [...]

Comments Off on New Generic Approval: Methimazole Coated Tablets (ANADA 200-814)

Recent Veterinary Drug Approval Updates: What Pharmacists Should Know

2025-07-14T14:45:05-05:00July 14th, 2025|Categories: News Release, Medication Safety, Veterinary Medicine, Veterinary Pharmacy, Veterinary Pharmacy - Small Animals|Tags: , |

Recent Veterinary Drug Approval Updates: What Pharmacists Should Know For ACVP Members and Veterinary Pharmacy Professionals Two recent FDA actions bring noteworthy changes to veterinary pharmacotherapy—particularly for pharmacists involved in compounding and those managing inventory of critical-use medications in clinical settings. ________________________________________ Felicyn-CA1 (sirolimus) – Conditional Approval for Management of Ventricular Hypertrophy in Cats [...]

Comments Off on Recent Veterinary Drug Approval Updates: What Pharmacists Should Know

Labeling Update Alert: Librela® (bedinvetmab injection), NADA 141-562

2025-04-08T16:15:45-05:00April 8th, 2025|Categories: News Release, Medication Safety, Veterinary Medicine, Veterinary Pharmacy|Tags: , |

Labeling Update Alert: Librela® (bedinvetmab injection), NADA 141-562 Overview Librela® (bedinvetmab injection), the first monoclonal antibody approved in the U.S. to control osteoarthritis pain in dogs, received important label updates on February 18, 2025, under NADA 141-562. These changes reflect data gathered from real-world post-approval use since its U.S. launch in October 2023. [...]

Comments Off on Labeling Update Alert: Librela® (bedinvetmab injection), NADA 141-562

Unapproved Pet Medications Are No Bargain—Here’s Why

2025-01-13T10:46:24-06:00January 13th, 2025|Categories: News Release, Medication Safety, Veterinary Medicine, Veterinary Pharmacy|Tags: , |

Unapproved Pet Medications Are No Bargain—Here’s Why Your pet’s health and well-being are paramount, and when it comes to managing serious conditions like idiopathic epilepsy and seizures, the stakes couldn’t be higher. Recently, the FDA issued warnings to six online sellers of unapproved drugs that claim to treat or control seizures in dogs [...]

Comments Off on Unapproved Pet Medications Are No Bargain—Here’s Why

12 Ways to Keep Your Pet Safe This Christmas

2024-12-18T09:37:35-06:00December 18th, 2024|Categories: News Release|Tags: , |

12 Ways to Keep Your Pet Safe This Christmas The holiday season is a magical time filled with decorations, festive foods, and joyous gatherings. But while you're decking the halls and celebrating with loved ones, it’s important to remember that some common holiday traditions can pose risks to your pets. From dangerous decorations [...]

Comments Off on 12 Ways to Keep Your Pet Safe This Christmas
Go to Top